MARGOT ANTONELLO: Open Payments
NPI 1720657182 · WYNNEWOOD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,150 in 55 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $162 · 2025 $1,150
Food & beverage: $1,150
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $318 |
| Medtronic, Inc. | 4 | $167 |
| Lilly USA, LLC | 10 | $158 |
| ABBVIE INC. | 5 | $107 |
| Amgen Inc. | 4 | $85 |
| SANOFI-AVENTIS U.S. LLC | 3 | $69 |
| Tandem Diabetes Care, Inc. | 3 | $69 |
| Amphastar Pharmaceuticals, Inc. | 3 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| Insulet Corporation | 1 | $27 |
Products named: JARDIANCE, Ozempic, MINIMED 780G, SYNTHROID, Rybelsus, TZIELD, t:slim X2 Insulin Pump with Control-IQ, REPATHA.
Industry payments across PA — which companies pay providers there.
